NCT00578292 2020-05-01
THALLO
Baylor College of Medicine
Phase NA Terminated
Clinical Trials
10 trialsNCT00038883 2018-11-07
Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies
M.D. Anderson Cancer Center
Phase NA Terminated
NCT00578539 2016-04-22
REGALE
Baylor College of Medicine
Phase NA Terminated
NCT00587847 2015-10-15
Campath Maintenance in Chronic Lymphocytic Leukemia
Northwell Health
Phase NA Terminated
NCT00073879 2015-01-29
Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation
Baylor College of Medicine
Phase NA Completed
NCT00021151 2014-01-09
Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia
Case Comprehensive Cancer Center
Phase NA Completed
NCT00525876 2011-12-07
Non-Myeloablative Allogeneic Stem Cell Transplantation
M.D. Anderson Cancer Center
Phase NA Completed
NCT00038844 2011-11-02
Safety and Efficacy of Campath in Nonmyeloablative Transplantation
M.D. Anderson Cancer Center
Phase NA Completed
NCT00582894 2011-04-22
Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases
University of Oklahoma
Phase NA Completed
NCT00336206 2006-07-25
Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia
Tawam Hospital
Phase NA Unknown